References
- Agarwal V, Siddiqui A, Ali H, Nazzal S. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int J Pharm, 2009;366:44–52
- Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int J Pharm, 2006;320:53–7
- Dastmalchi S, Garjani A, Maleki N, Sheikhee G, Baghchevan V, Jafari-Azad P, Valizadeh H, Barzegar-Jalali M. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J Pharm Pharm Sci, 2005;8:175–81
- Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm, 2007;329:166–72
- Dora CP, Singh SK, Kumar S, Datusalia AK, Deep A. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Pol Pharm, 2010;67:283–90
- Elbary AA, Salem HF, Maher ME. In vitro and in vivo evaluation of glibenclamide using surface solid dispersion (SSD) approach. British J Pharmacol Toxicol, 2011;2:51–62
- Esclusa-Díaza MT, Torres-Labandeira JJ, Katab M, Vila-Jatoa JL. Inclusion complexation of glibenclamide with 2-hydroxypropyl-β-cyclodextrin in solution and in solid state. Eur J Pharm Sci, 1994;1:291–96
- Ford JL, Mann TE. Fast-Scan DSC and its role in pharmaceutical physical form characterisation and selection. Adv Drug Deliv Rev, 2012;64:422–30
- Galal S, EL-Massik M, Abdallah O, Daabis N. Formulation of fast release glibenclamide liquid and semi-solid matrix filled capsules. Acta Pharm, 2003;53:57–64
- Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm, 2007;341:26–34
- Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm, 2001;212:233–46
- Malcolmson C, Satra C, Kantaria S, Sidhu A, Lawrence MJ. Effect of oil on the level of solubilization of testosterone propionate into non-ionic oil-in-water microemulsions. J Pharm Sci, 1998;87:109–16
- Mu H, Holm R, Mullertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm, 2013;453:215–24
- Nazzal S, Smalyukh, II, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: Mechanism and progress of emulsion formation. Int J Pharm, 2002;235:247–65
- Nipun TS, Islam SMA. SEDDS of gliclazide: Preparation and characterization by in-vitro, ex-vivo and in-vivo techniques. Saudi Pharm J, 2013; DOI: 10.1016/j.jsps.2013.06.001 (in press)
- Nnamani PO, Attama AA, Ibezim EC, Adikwu MU. SRMS142-based solid lipid microparticles:application in oral delivery of glibenclamide to diabetic rats. Eur J Pharm Biopharm, 2010;76:68–74
- Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev, 2008;60:673–91
- Pouton CW. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci, 2000;11(Suppl 2):S93–8
- Serrano-Martin X, Payares G, Mendoza-Leon A. Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis. Antimicrob Agents Chemother, 2006;50:4214–6
- Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm, 1998;166:177–88
- Staniforth J. 2002. Powder flow. In: Aulton ME, ed. Pharmaceutics: The science of dosage form design. 2nd ed. NY: Churchill Livingstone, pp. 187–98
- Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res, 1994;11:1132–42
- Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm, 2000;198:7–27